Step 1 topics → Cardiovascular → Heart Failure Types (HFrEF / HFpEF / Right-Sided)

Heart Failure Types (HFrEF / HFpEF / Right-Sided)

USMLE Step 1 trap: Incorrectly extends HFrEF mortality-benefit drugs to HFpEF. No drug class has demonstrated clear mortality benefit in HFpEF; management focuses on symptom control with diuretics and treating underlying causes such as hypertension and AF.

Heart failure types are tested heavily on USMLE Step 1 because they require you to integrate pathophysiology, physical exam findings, and management all at once. Students consistently apply HFrEF drug regimens to HFpEF, but no drug class has proven mortality benefit in HFpEF — the GDMT toolkit of ACEi, beta-blockers, MRAs, and SGLT2i is for reduced-EF disease only, and transplanting it to preserved-EF disease is a testable error. The core framework: HFrEF (EF <40%) is a dilated, weak ventricle that can't squeeze; HFpEF (EF ≥50%) is a stiff ventricle that can't relax and fill. Right-sided HF is a separate beast — usually a consequence of left-sided HF or pulmonary hypertension — and its presentation is almost the mirror image of left-sided HF. Get these three phenotypes locked in your head as distinct clinical pictures before you try to memorize anything else.

The exam will test you on all three presentation types but loves to trip you up by mixing their findings. A classic USMLE Step 1 move: describe an elderly obese hypertensive woman with dyspnea and a normal EF on echo — students who think 'heart failure = low EF' will miss HFpEF entirely. Another trap is the management question asking which drugs reduce mortality: HFrEF has a robust GDMT toolkit (ACEi/ARB, beta-blockers, MRA, SGLT2i, ARNI), but HFpEF has no drug class with proven mortality benefit — only symptom control. Students routinely apply HFrEF drugs to HFpEF on the exam and get burned.

Right-sided HF confuses students most on physical exam questions. The reflex is to think 'failing heart → pulmonary edema → crackles,' but right-sided HF backs up into the systemic venous system, not the lungs. You get JVD, hepatomegaly, and pitting edema in the legs — with clear lungs. Knowing which direction each ventricle drains is the key to never getting these mixed up. USMLE Step 1 will give you a clinical vignette and expect you to pick the right set of findings without second-guessing yourself.

From real student decks
95%have cards covering this topic
89%have mature cards
2median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: The same GDMT drugs proven in HFrEF (ACEi, beta-blocker, MRA) also confer mortality benefit in HFpEF.
Right: No drug class has demonstrated clear mortality benefit in HFpEF; management focuses on symptom control with diuretics and treating underlying causes such as hypertension and AF.
The drugs proven to reduce mortality in HFrEF work by offloading a dilated, volume-overloaded ventricle and reversing pathological remodeling — mechanisms that are simply not the core problem in HFpEF. HFpEF is driven by diastolic stiffness, and while SGLT2 inhibitors show some emerging benefit, no drug class has convincingly demonstrated mortality reduction in HFpEF trials (CHARM-Preserved, I-PRESERVE). For Step 1 purposes, treat HFpEF symptoms with diuretics and aggressively manage the underlying causes — hypertension and atrial fibrillation — not by transplanting the HFrEF drug regimen.
Common mistake
Wrong: Right-sided heart failure presents with pulmonary edema and crackles because the heart is failing.
Right: Right-sided heart failure causes systemic venous congestion (JVD, hepatomegaly, peripheral edema) with clear lungs because the backup is upstream of the pulmonary circuit.
Think about the anatomy: the right ventricle receives blood from the systemic venous circulation and pumps it into the pulmonary circulation. When the right ventricle fails, blood dams up behind it — in the systemic veins — causing JVD, congestive hepatomegaly, and peripheral edema. The lungs are not directly upstream of the RV, so pulmonary edema and crackles are absent unless there is concurrent left-sided failure. Crackles are the hallmark of left-sided (pulmonary) congestion, not right-sided congestion.
Common mistake
Wrong: A reduced ejection fraction is required to diagnose heart failure.
Right: HFpEF is defined by heart failure symptoms with preserved EF (≥50%) due to diastolic dysfunction, and is more common in elderly, obese, hypertensive women.
Ejection fraction measures how much blood is pumped out with each beat — it reflects systolic function. HFpEF is a disease of diastolic dysfunction: the ventricle is stiff and cannot relax properly to fill, but it still squeezes normally, so EF is preserved (≥50%). Patients still have all the symptoms of heart failure (dyspnea, exercise intolerance, edema) because filling pressures are elevated. The diagnosis requires symptoms + preserved EF + evidence of diastolic dysfunction, not a low EF.
Common mistake
Wrong: An S4 gallop is the hallmark auscultatory finding of HFrEF.
Right: An S3 gallop is the hallmark of HFrEF, reflecting rapid ventricular filling into a dilated, volume-overloaded ventricle; S4 is more characteristic of diastolic dysfunction (HFpEF) or hypertrophy.
The S3 and S4 gallops reflect completely different physiology. S3 occurs during early rapid ventricular filling (diastole) — when blood rushes into an already volume-overloaded, dilated ventricle in HFrEF, the sudden deceleration creates a low-pitched thud. S4 occurs during late filling when the atrium contracts against a stiff, non-compliant ventricle — that's HFpEF or hypertrophic states. Match S3 to dilated/volume-overloaded (HFrEF) and S4 to stiff/hypertrophied (HFpEF, hypertensive heart disease) and you will never swap them on the exam.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a clinical vignette, identify HFrEF by its reduced ejection fraction (<40%), dilated left ventricle, S3 gallop, and signs of pulmonary congestion (crackles, orthopnea, PND).
  2. Recognize HFpEF in a patient with heart failure symptoms but preserved EF (≥50%), especially in an elderly, obese, hypertensive woman, and understand that diastolic dysfunction is the underlying mechanism.
  3. Identify right-sided heart failure by its systemic venous congestion findings — JVD, hepatomegaly, peripheral pitting edema — and recognize that the lungs are clear because the backup is upstream of the pulmonary circuit.
  4. Distinguish GDMT for HFrEF (ACEi/ARB/ARNI, beta-blockers, MRA, SGLT2i — all with mortality benefit) from HFpEF management (diuretics for symptoms, treat HTN and AF — no mortality-proven drug class).

Can you avoid these mistakes?

A 72-year-old obese woman with a long history of hypertension presents with dyspnea on exertion and lower extremity edema. Echocardiogram shows an EF of 58% with impaired relaxation. What type of heart failure does she have, and what is the goal of pharmacologic management?
On auscultation of a patient with known dilated cardiomyopathy, you hear an extra heart sound just after S2. What is this sound, what does it indicate, and how does it differ from the extra sound you would expect in a patient with a stiff, hypertensive ventricle?
A patient with severe COPD and pulmonary hypertension presents with 3+ pitting edema to the knees, JVD, and a tender, enlarged liver. Lung auscultation is clear. Which ventricle is failing, and why are the lungs clear?
You are comparing two heart failure patients: one with EF 30% (HFrEF) and one with EF 55% (HFpEF). Which drug classes have evidence for reducing mortality in the first patient? Which drugs are used in the second, and what is the goal of treatment?

Related topics

Cardiac Output and Determinants Heart Development and Looping Cardiac Septation Fetal Circulation and Transition Coronary Arteries and Territories

See how your Anki deck covers this topic.

Upload your deck for a free audit →